HIGH POINT , NC — Banner Pharmacaps, a global drug delivery company and leader in softgel technology, has introduced a unique controlled release platform. The proprietary, softgel-based delivery system offers tailored controlled release patterns for a wide variety of drugs to minimize adverse reactions and maximize efficacy.
Pharmaceutical companies can now introduce new products or maximize the lifecycle extension of existing products and brands by utilizing Banner’s patent pending technology. Augmenting the numerous therapeutic advantages of the controlled release concept with softgels provide numerous opportunities to the pharmaceutical industry.
“The science of controlled release has become an independent research discipline from which its future depends on a thorough understanding of the dynamic interactions between the drug, the delivery system, and biological environment and barriers,” says Dr. Emad Hassan, senior manager of formulation development at Banner.
Hassan says that it is always achievable to prolong and/or control the amount and duration of the release of an active ingredient(s). However, the design of a successful controlled release product cannot be achieved through simple or complex mathematics. “The biochemistry and biophysics of our gastrointestinal system should be carefully accounted for while crafting this kind of product,” says Hassan. Organ emptying rate or motility, pH, digestive enzymes and biological surfactants make the journey of a unit dosage form throughout the gastro-intestinal tract (GIT) highly unpredictable.
According to Hassan, controlled release products, now available in a softgel dosage form, will enable patients to take fewer dosages of their medication, gain a more consistent effect and experience lesser frequency of side effects.
Banner is a global company that researches, develops, and manufactures drug delivery technologies and proprietary healthcare products. With state-of-the-art, FDA-approved manufacturing facilities and significant investment in research and development, Banner provides innovative oral delivery solutions and unique products to the health care industry worldwide. A wholly owned subsidiary of Sobel N.V., Banner has operations in the United States, Canada, Europe, Latin America and Asia-Pacific.